Get the Stockscreener App
0.135
87.50%
0.063
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.135, with a volume of 61,016.
It is up +87.50% in the last 24 hours and up +87.50% over the past month.
PROPHASE LABS INC
See More
Previous Close:
$0.072
Open:
$0.1223
24h Volume:
61,016
Relative Volume:
2.51
Market Cap:
$N/A
Revenue:
$7.33M
Net Income/Loss:
$-21.20M
P/E Ratio:
-0.1477
EPS:
-0.9143
Net Cash Flow:
$-12.68M
1W Performance:
+87.50%
1M Performance:
+87.50%
6M Performance:
-95.33%
1Y Performance:
-96.64%
1-Day Range:
$0.1223
$0.145
1-Week Range:
$0.1223
$0.145
52-Week Range:
$0.07
$0.145
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
-
Address
-
Compare PRPH vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.135 | 0 | 7.33M | -21.20M | -12.68M | -0.9143 |
TMO
Thermo Fisher Scientific Inc
|
469.21 | 174.37B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
175.15 | 123.97B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.46 | 45.07B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.52 | 32.36B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
307.12 | 30.15B | 3.17B | 642.63M | 516.49M | 10.77 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
MSN Money - MSN
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ProPhase Labs earnings missed by $2.47, revenue fell short of estimates - Investing.com Canada
ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform - The Manila Times
ProPhase Labs Reports Year-End 2025 Results, Highlights - GlobeNewswire
Geopolitics Watch: What analysts say about ProPhase Labs Inc stock2026 Gainers & Target Return Focused Stock Picks - baoquankhu1.vn
ETF Watch: Is ProPhase Labs Inc exposed to political riskMarket Movement Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn
Street Watch: Is ProPhase Labs Inc exposed to currency risksRate Cut & Daily Profit Focused Stock Screening - baoquankhu1.vn
Prophase Labs Stock Price Forecast. Should You Buy PRPH? - StockInvest.us
Earnings Update: How much upside does ProPhase Labs Inc have2026 Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Will ProPhase Labs Inc outperform the market in YEARTrade Performance Summary & Safe Entry Point Alerts - baoquankhu1.vn
Nasdaq Moves: Will ProPhase Labs Inc benefit from AI trends2026 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Market Review: Whats next for ProPhase Labs Inc stock2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn
ProPhase Labs (NASDAQ:PRPH) versus Medicure (OTCMKTS:MCUJF) Financial Contrast - Defense World
ProPhase Labs, Inc. (PRPH) stock price, news, quote and history - Yahoo Finance UK
Risk Hedge: Is ProPhase Labs Inc exposed to political risk2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
Quarterly Risk: How does ProPhase Labs Inc score in quality rankings2026 Trading Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
ProPhase Labs Delays Annual 10-K Yearly Filing - TipRanks
ProPhase Labs (PRPH) notifies SEC of delayed FY2025 10-K; expects 15-day filing - Stock Titan
Guidance Update: Is ProPhase Labs Inc exposed to political risk2026 Snapshot & Weekly High Return Opportunities - baoquankhu1.vn
Trend Recap: What analysts say about ProPhase Labs Inc stockIndex Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Investment Recap: How much upside does ProPhase Labs Inc have2026 Macro Impact & Verified Entry Point Detection - baoquankhu1.vn
Gains Report: What analysts say about ProPhase Labs Inc stockQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
ProPhase Labs (PRPH) Updates on Crown Medical Collections Progre - GuruFocus
ProPhase Labs provides business update highlighting advancing Crown Medical collections activity - marketscreener.com
ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity - The Manila Times
Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity - TradingView
Biotech seeks insurer recoveries from 250+ payors for receivables-backed cash - Stock Titan
Big Picture: What analysts say about ProPhase Labs Inc stockQuarterly Growth Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Financial Analysis: ProPhase Labs (NASDAQ:PRPH) versus Ono Pharmaceutical (OTCMKTS:OPHLF) - Defense World
Aug Swings: How correlated is ProPhase Labs Inc to the S P500Earnings Overview Summary & Verified Short-Term Plans - baoquankhu1.vn
Short Covering: What analysts say about ProPhase Labs Inc stockVolume Spike & Long-Term Investment Growth Plans - baoquankhu1.vn
Guidance Update: Whats next for ProPhase Labs Inc stockJuly 2025 Final Week & Precise Buy Zone Identification - baoquankhu1.vn
Head-To-Head Review: ProPhase Labs (NASDAQ:PRPH) & Enliven Therapeutics (NASDAQ:ELVN) - Defense World
PRPH SEC FilingsProphase Labs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Advanced Biological Laboratories S.A. cancelled the acquisition of ProPhase Labs, Inc. in a reverse merger transaction. - marketscreener.com
ProPhase Labs Hosts Investor Webinar on Growth Portfolio - TipRanks
ProPhase Labs Initiates Potential Sale or Strategic - GlobeNewswire
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd - GlobeNewswire
ProPhase Labs Issues Update on Crown Medical Collections - TipRanks
ProPhase Labs (PRPH) Provides Update on COVID-19 Receivables Col - GuruFocus
ProPhase Labs Secures Funding and Completes Market Transition Following Reverse Stock Split - AD HOC NEWS
ProPhase Labs enters $10 million equity line agreement with Generating Alpha - Investing.com
Off the Pink Sheets: ProPhase Labs shifts to OTC market - Stock Titan
Prophase Labs Approves Strategic Proposals at Special Meeting - MSN
ProPhase Labs, Inc.Common Stock (NQ: PRPH - FinancialContent
ProPhase Labs Updates Shareholders Amid Volatility and OTC Move - TipRanks
ProPhase Labs Announces Immediate Resignation of Board Member - TipRanks
ProPhase Labs Announces Board Resignation - TradingView — Track All Markets
Is ProPhase Labs Inc. stock a safe haven asset2025 Pullback Review & Weekly Watchlist of Top Performers - ulpravda.ru
How ProPhase Labs Inc. stock compares to market leadersCEO Change & Low Drawdown Trading Techniques - ulpravda.ru
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
0.54%
Cap:
|
Volume (24h):